The global urinalysis market is expected to reach USD 2.94 billion by 2026, growing at a CAGR of 8.6 percent during 2019 to 2026, elucidates Research and Markets. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market, which is driven by growing incidences of UTI and other kidney diseases.
The consumables segment dominated this market in 2019. The urinalysis consumables market is segmented into pregnancy and fertility kits, dipsticks, reagents, and disposables. Pregnancy and fertility kits accounted for the largest share of this market in 2019. These kits have witnessed wide adoption amongst end users across the globe owing to their cost-effectiveness and ease of use. In 2019, the disease-screening segment accounted for the largest market share owing to the fact that urine analysis has become a part of the general check-up in hospitals and clinics. Pregnancy and fertility testing is carried out using the kits available in the market either in homecare settings or in clinics.
North America, which includes the US and Canada, accounted for the largest share of the urinalysis market. The growth in this market is primarily driven by the increasing prevalence of UTIs and kidney diseases, rising geriatric population, favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and availability of technologically advanced urinalysis instruments.
Major players operating in the urinalysis market are Seimens Healthineers, Roche Diagnostics, Cardinal Health, Arkray Inc., Sysmex Corporation, Alere Inc., Beckman Coulter, Bio-Rad Laboratories, 77 Elektronika Kft, and Dirui, Acon Laboratories, Quidel Corporation, and Urit Medical Electronic Ltd.